Elevated Immune Response Among Children 4 Years Of Age With Pronounced Local Adverse Events After The Fifth Dtap Vaccination
Pediatric Infectious Disease Journal, ISSN: 1532-0987, Vol: 36, Issue: 9, Page: e223-e229
2017
- 7Citations
- 22Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations7
- Citation Indexes4
- CrossRef4
- Policy Citations3
- Policy Citation3
- Captures22
- Readers22
- 22
Article Description
BACKGROUND:: In the Netherlands, acellular pertussis vaccines replaced the more reactogenic whole-cell pertussis vaccines. This replacement in the primary immunization schedule of infants coincided with a significant increase in pronounced local adverse events (AEs) in 4 years old children shortly after the administration of a fifth diphtheria, tetanus, acellular pertussis and inactivated polio (DTaP-IPV) vaccine. The objective of this study was to investigate possible differences in vaccine antigen-specific immune responses between children with and without a pronounced local AE after the fifth DTaP-IPV vaccination. METHODS:: Blood was sampled in two groups of four year olds: a case group reporting pronounced local swelling and/or erythema up to extensive limb swelling at the injection site (n=30) and a control group (n=30). PBMCs were stimulated with individual vaccine antigens. Plasma antigen-specific IgG, IgG-subclass and total IgE concentrations, and T-cell cytokine (IFN-γ, IL-13, IL-17 and IL-10) production by stimulated PBMCs were determined by multiplex bead-based-fluorescent multiplex immunoassays. RESULTS:: In children with AEs, significantly higher total IgE and vaccine antigen-specific IgG and IgG4 responses as well as levels of the Th2 cytokine IL-13 were found after pertussis, tetanus and diphtheria stimulation compared with controls. CONCLUSIONS:: Children with pronounced local reactions show higher humoral and cellular immune responses. Acellular vaccines are known to skew towards more Th2 responses. The pronounced local AEs may be associated with more Th2-skewing after the fifth DTaP-IPV vaccination, but other biologic factors may also impact the occurrence of these pronounced local reactions.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85017883141&origin=inward; http://dx.doi.org/10.1097/inf.0000000000001620; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85018855504&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/28430750; http://Insights.ovid.com/crossref?an=00006454-201709000-00018; https://journals.lww.com/00006454-201709000-00018; https://dx.doi.org/10.1097/inf.0000000000001620; https://journals.lww.com/pidj/Fulltext/2017/09000/Elevated_Immune_Response_Among_Children_4_Years_of.18.aspx
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know